Amery A, Van Hoof R, Bielen E, Fagard R, Staessen J, Thijs L, Vanhees L
Department of Pathophysiology, University of Leuven, Belgium.
Acta Cardiol. 1989;44(4):269-87.
Angiotensin-converting enzyme inhibitors are gaining acceptance as safe and effective agents for treatment of hypertension. Addressed in this review of the available literature are the questions whether they are effective in lowering blood pressure in the elderly, whether their effects are age-related, and what effects, if any, do they have on morbidity and mortality in geriatric hypertension.
血管紧张素转换酶抑制剂作为治疗高血压的安全有效药物正逐渐被人们所接受。本综述探讨了现有文献中关于它们在老年人中降低血压是否有效、其效果是否与年龄相关以及它们对老年高血压患者的发病率和死亡率有何种影响（若有影响的话）等问题。
